Anti-Malarial Tablets for Kenya

by

QUESTION

Which are the best tablets to take against malaria in Kenya?
Is there a malaria vaccination?

ANSWER

I’ll answer your second question first—no, there does not yet exist a commercially available malaria vaccine. Currently, one promising vaccine candidate is undergoing Phase 3 clinical trials in children in sub-Saharan Africa; recently published preliminary findings suggest that it provides roughly 50% protection against malaria.

As for which tablets you should take, there are a number of options, and choosing between them is basically a matter of personal preference. The three main kinds recommended for sub-Saharan Africa are doxycycline, atovaquone/proguanil combination (sold under the brand name Malarone) and mefloquine (sold as Lariam). These three differ in how you take them (usually once a day for doxycycline and Malarone and once a week for Lariam), how expensive they are (doxycycline is the cheapest, Malarone the most expensive) and the side effects you might experience (sun sensitivity is a big problem for some people on doxycycline, some people report hallucinations on Lariam, whereas Malarone usually has the fewest severe side effects).

If you’re not sure what’s best for you, you can always talk it over with your doctor when asking for the prescription, and they might have recommendations, based on their knowledge of your health and specific requirements.

It is worth noting that levels of chloroquine resistance are very high in sub-Saharan Africa, and so chloroquine is not recommended as a prophylactic when travelling to this region.

Paludisme Depuis 5 Mois (Malaria for 5 Months)

by

QUESTION:

En fait je souffre d’un palu que le médécin a mal traité après une analyse sanguine. J’aimerais savoir comment faire pour m’en débarrasser car je traine ce palu maitenant depuis 5 mois.

ENGLISH TRANSLATION:

In fact I suffer from malaria which the doctor has treated poorly after a blood test. I would like to know how to clear myself of this because I have been carrying this malaria now for 5 months.

ANSWER:

C’est rare de souffre telle longtemps que 5 mois continuellement avec palu; plus commun c’est de observer plusieurs episodes d’infection en serie, si la traitement n’est-ce pas un succes. Mais tout ca depend un peu du type du palu. Vous devrez tenir un autre test sanguine pour determiner ce type du palu, de preference au hôpital ou dans un clinique de santé. Avec celle information, le médécin peut vous recommender un traitement approprié. Par example, si vous avez un infection de Plasmodium vivax ou P. ovale, le parasite peut rester en repos dans le foie pendant plusieurs semaines ou bien plusieurs mois. Des médicaments qui traitent l’infection dans le sang, comme chloroquine ou ACTs, ne touchent pas cette stages de vie dans le foie. Dans ce cas, vous devez parler avec votre médécin sur un autre médicament, qui s’appelle primaquine, qui tue a les parasites dans le foie et previent encore plus de rechutes.

ENGLISH TRANSLATION: It’s rare to suffer from malaria continuously for five months; it is more common to see multiple infections over and over in series, if the disease is not treated appropriately. But all of this depends on the type of malaria that you have. You need to have another blood test to determine the type of malaria, and based on this information, the doctor can give you appropriate treatment. For example, if you have Plasmodium vivax or P. ovale, the parasite can rest dormant in the liver for several weeks or even months. The drugs which treat the initial infection in the blood, such as chloroquine or ACTs, don’t affect these liver stages. In this case, you must talk to your doctor about taking another medication, called primaquine, which kills the liver stages of the malaria parasite and prevents further relapses of the disease.

Treatment for Malaria

by

QUESTION:

What is the main medicine to cure malaria and about safety precautions?

ANSWER:

There are a number of medicines used to treat malaria. Traditionally, chloroquine has been the first line drug of choice for uncomplicated, non-resistant malaria. However, several types of malaria, and most notably Plasmodium falciparum, the most severe and deadly kind, has become resistant to chloroquine in many places. In some parts of south-east Asia, Plasmodium vivax has also begun to show worrying signs of chloroquine resistance. In such settings, where resistance to chloroquine is suspected, the first line medications for uncomplicated cases are artemisinin-based combination therapies (ACTs), such as Coartem.

The World Health Organization has recommended that artemisinin only be given in combination with another drug to prevent malaria also becoming resistant to this therapy as well. Cases of malaria which have progressed beyond the grasp of that treatable with oral medication as described above (so-called “complicated” cases, most common with P. falciparum infection) are usually given intravenous quinine as a first-line response.

All of these treatments have been rigorously tested in strictly controlled clinical and field trials, and while they may have side effects, they are generally mild and in most cases, the patient will be given the dose without prior testing for reaction to the drug. One exception is with primaquine, which is sometimes used as a preventative medication against malaria and can also be used to treat the liver stages of P. vivax and P. ovale. Primaquine is known to cause severe haemolysis in people with G6DP deficiency, and so people with a high statistical probability of having this condition (for example due to family history or ethnicity) should be tested prior to being given primaquine.

I am getting malaria every 6 months

by

QUESTION:

I am getting malaria every six months, after taken chloroquine medicine tablets. Is this  normal,when my resistance is low, or is it coming aging, is there any medicine to clear the malaria?

ANSWER:

While taking chloroquine can be used to treat malaria, it will not prevent re-infection, unfortunately. One thing to check though is whether you are living in an area where the local types of malaria might be resistant to chloroquine; if so, it will be worth seeing if you can be treated with artemisinin-based combination therapies (ACTs), such as Coartem or Lonart, instead.

Again, these will not prevent re-infection, however, so you need to also take other preventative actions, such as sleeping under a long-lasting insecticide treated bednet and wearing long-sleeved clothing in the evenings and at night to prevent mosquito bites.

It sounds from your question like you live in an area where malaria is common; however, if you are actually only travelling to malarial areas regularly, you could also ask your doctor about the possibility of taking preventative medicine against malaria for the time that you are travelling (these are called “prophylactics”).

You should also check which species of malaria parasite you are infected with – this can be determined when you are diagnosed with the infection, either through looking at your blood under a microscope or by using a rapid diagnostic test (RDT). If you Plasmodium ovale or Plasmodium vivax, there is a possibility that even though the initial acute phase of the infection is responding to treatment with chloroquine, the parasite is remaining dormant in your liver, and causing the recurrences every 6 months. In this case, you should ask your doctor about the possibility of taking a drug called primaquine, which kills these liver stages and prevents further relapse of the disease.

Dengue Fever

by

QUESTION:

Hello, I work with an NGO . We work in the rural areas. Please give me idea about dengue. Thnx

ANSWER:

Hi there, I’m afraid that I can’t really help you without knowing where you are located! Also, this forum is generally dedicated to questions about malaria, and so maybe I could recommend you look at the World Health Organisation pages regarding dengue fever for more information.

Certainly there are some very interesting data regarding the possible relationship between chloroquine resistance in malaria (and thus the reduction in prescribing it for malaria treatment) and the increase in incidence of dengue in many areas, but that’s a whole different story!

Drugs to Treat Pregnant Woman with Malaria

by

QUESTION:

What are the drugs for a pregnant woman who has malaria for the first to third trimester?

ANSWER:

The treatment of malaria in pregnant women has become more challenging in recent years, as many types of malaria are developing resistance to the standard arsenal of drugs. In locations where the dominant form of malaria is still chloroquine-sensitive, chloroquine can be used safely throughout pregnancy.

However, given the high levels of chloroquine-resistance, other drug regimens may be required. Currently, first-line treatment options for uncomplicated malaria caused by Plasmodium falciparum (many strains of which are resistant to chloroquine), is quinine plus clindamycin (doxycycline is contraindicated in pregnant women). In the second and third trimesters, artesunate plus clindamycin can be administered, or the artemisinin-based combination therapy (ACT) commonly used in that region, although some of these combinations, particularly those containing artemether, have limited safety testing in pregnant women. In general, the paucity of controlled, randomized trials has posed a problem to creating safe and effective recommendations for the treatment of malaria in pregnant women.

Clinical malaria, taking chloroquine

by

QUESTION:

Patient having malaria. Taking chloroquine. Then temp becomes normal but headache occurred. What to do?

ANSWER:

One of our collaborating medical doctors kindly assisted in answering this question. She suggests more clinical information is required; what type of malaria is the chloroquine being used for, for example? Also, the headache should not be from the drug, suggesting there is another cause which should be investigated.

Treatment for Pregnant Woman with P. Vivax Malaria

by

QUESTION:

A pregnant woman has vivax malaria what treatment should be given in case of relapse?

ANSWER:

Primaquine, the usual drug given to prevent relapse of P. vivax malaria, is not recommended for pregnant women due to inadequate information about its safety. As such, it is normally recommended to treat the relapses with chloroquine, to cure each malarial episode, until after delivery of the child, after which time the woman should be treated with primaquine.

Malaria Re-occurrence

by

QUESTION:

I’ve been infected with malaria vivax, for this i’ve taken the treatment for three days, after three days i don’t have any symptoms but after two days again I’m feeling the fever and abdominal pain which i’m having since the diagnosis is still persisting. Why is it happening? Are there any chances even after treatment for re-occurrence? My urine is yellow color but there is no jaundice?

ANSWER:

“Vivax” malaria, caused by the parasite Plasmodium vivax, is known for cyclical fevers every couple of days. As such, it may be that while the medication is working, you are still experiencing some mild symptoms as the infection is not completely cleared. For this reason, it is very important to take the full course of medication prescribed to you by your doctor; DO NOT stop taking it as soon as you feel better, as you might not have killed all of the malaria parasites in your blood, putting yourself at risk for the infection to persist. Alternatively, it might be that the strain of P. vivax you have is not responding to the medication you have been given; in parts of Papua New Guinea and Indonesia, for example, the local strains of P. vivax have been shown to have high levels of chloroquine resistance, which is usually used for treating P. vivax. If you are located in an area of known P. vivax resistance to chloroquine, your doctor should be able to recommend a different regimen of treatment to ensure that the infection is cured thoroughly. You should take a blood test after completing treatment to be sure that the parasite is no longer in your blood stream. In addition, P. vivax can produce dormant liver stages called hypnozoites that can remain within the liver hepatocyte cells and cause relapse or recurrence of the disease many weeks or months after the initial infection. To destroy these liver stages, and thus prevent relapse, you should ask your doctor about taking another drug once you have completed your initial treatment. This second drug is called primaquine, and will kill the P. vivax hepatocytes.

Causes of malaria, treatment with drugs and emerging resistance

by

QUESTION:

What is malaria and what causes it besides bacteria? What is the name of the causal agent for malaria, which drug is used to cure it and how do the pathogens become resistant to the drugs?

ANSWER:

There are many questions in there! Malaria is actually caused by a single-celled animal, called a protozoan; it’s not a bacterial disease. There are different species of these protozoans, which form a genus called Plasmodium; the different species cause different types of malaria, for example Plasmodium falciparum, the most deadly and severe form, and Plasmodium vivax, which is widespread throughout the world but is a less acute infection. These different forms of malaria are each treated with different medications, depending on what is most effective and available; P. vivax, for example, can be treated with chloroquine, whereas in many places, P. falciparum has become resistant to this drug. In areas where resistance to chloroquine has emerged, other drugs are used; in Africa, artemisinin-based combination therapies (ACTs) are commonly used against chloroquine-resistant P. falciparum. Other drugs used to treat malaria include quinine compounds such as quinine sulphate, mefloquine, sulfadoxine-pyrimethamine and medications combining proguanil with atovaquone (marketed as Malarone).

The emergence of resistance to these drugs is a worrying phenomenon with respect to malaria; it is such a widespread and deadly disease, that the consequences of failed treatment are very high. Resistance can be caused by many factors, at the level of the drug, the human host, the mosquito host and also the malaria parasite itself. For example, poor drug compliance during treatment can lead to a failure to clear an infection completely, allowing the remaining parasites, which were less susceptible to the drug, to survive and reproduce. With successive generations, natural selection will lead to the evolution of strains of malaria parasites which are firmly resistant to that drug. The same process occurs when mass drug administration programmes, for example in areas of high malaria endemicity, give people sub-therapeutic doses of medication (in other words, doses of the drug that are too low to kill the parasite). Another problem is when people are not checked for their infection status after having been treated for malaria; if treatment fails for some reason, they will still have parasites in their blood, and should be treated again to ensure that all the malaria has been killed. If this doesn’t happen, the parasites can carry on reproducing, as in the processes described above. For these reasons, it is crucially important for people to be given accurate doses of medication, to ensure that they complete the full course of treatment, and that once treatment has been completed, they are accurately tested as negative for the malaria parasite. Finally, there are factors related to the affinity of the malaria parasite to its vector mosquito hosts which can lead to the emergence of drug resistant strains. For example, it has been shown that strains of malaria which are resistant to chloroquine are better able to survive and reproduce inside their mosquito hosts, leading to a greater population size of resistant parasites compared to drug-susceptible ones. It is for these reasons that malaria treatment and control programmes are now being very careful with the ways in which they administer drugs and monitor infections, in order to limit any further reisstance developing; similarly, pharmaceutical and biochemical researchers are constantly on the look-out for new compounds or methods of killing malaria parasites, which can be developed into new forms of treatment.